Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Lithium Ionic: 2024 Year-in-Review, Setting Stage for a Pivotal 2025
-
Microbix Expanding Addressable Market Share with Test Makers Augmenting its Recombinant Antigen Capabilities for Immunoassay Markets
-
Lantronix CEO Saleel Awsare Named “IoT Company CEO of the Year” in 2025 IoT Breakthrough Awards Program
-
Volvo Cars Canada named official automotive partner of Canada Snowboard
-
Tiziana Life Sciences Announces Review Article Published in Nature Highlighting Foralumab's Potential in the Treatment of Neurological Disease
-
Ceragon to Participate at the Needham Growth Conference
-
Azul Announces Early Participation Results for the Previously Announced Exchange Offer in respect of Existing 2028 First Out Notes for New Notes and Solicitation of Consents to Proposed Amendments to
-
Gatekeeper Leads the Way in Financial Services Compliance by Achieving DORA Readiness
-
AI-Driven Crypto research platform SoSoValue raises $15 million Series A to launch the Investible Spot Index Protocol SSI
-
1cBio and Alesta Therapeutics Announce Exclusive Global Licensing Agreement for a Novel Potentially First-in-Class Small Molecule for Hypophosphatasia
-
ASDSA Finds Lack of Physician Supervision in Medical Spas
-
Shutterstock Appoints Matt Furlong as Chief Marketplace Officer
-
Mirror Biologics Enters Clinical Collaboration with Merck KGaA, Darmstadt, Germany in Metastatic Colorectal Cancer
-
CB&I Awarded Contract by TJN Ruwais LNG Joint Venture for its LNG Project Located in Abu Dhabi, UAE
-
AerCap Holdings N.V. To Release Fourth Quarter 2024 Financial Results on February 26, 2025
-
The OCIO Industry is Substantially Larger than Previously Estimated
-
Study Advances Possible Blood Test for Early-Stage Alzheimer's Disease
-
Quarterhill Announces CFO Departure
-
Azul Announces Early Participation Results for the Previously Announced Exchange Offers in respect of Existing 2029 Second Out Notes and Existing 2030 Second Out Notes for New Notes and Solicitations
-
Ocular Therapeutix™ to Provide Corporate Update During 43rd Annual J.P. Morgan Healthcare Conference Presentation
-
Agora and Galaxy Execute First OTC Transaction of AUSD Stablecoin
-
Halozyme Reiterates 2024 Financial Guidance and Raises 2025 and Multi-Year Financial Guidance
-
LB Pharmaceuticals Announces Positive Topline Results from Phase 2 Trial of LB-102 in Schizophrenia
-
The Simply Good Foods Company Reports Fiscal First Quarter 2025 Financial Results and Reaffirms Fiscal Year 2025 Outlook
-
Compugen Announces First Patient Dosed in Phase 1 Clinical Trial to Evaluate COM503 as Monotherapy and in Combination with Zimberelimab in Advanced Solid Tumors
-
Army Chooses AiRANACULUS to Develop Intelligent Navigation Antenna System
-
Canadian Solar's e-STORAGE to Deliver 2 GWh of Energy Storage Systems in the UK for Copenhagen Infrastructure Partners
-
FDA Accepts Agios’ Supplemental New Drug Application for PYRUKYND® (mitapivat) in Adult Patients with Non-Transfusion-Dependent and Transfusion-Dependent Alpha- or Beta-Thalassemia
-
I-Mab Announces Open Market Purchases of Company American Depositary Shares by Board Member
-
Boston Scientific Announces Agreement to Acquire Bolt Medical, Inc.
-
MediPharm Labs Enters Landmark Commercial Agreement with Laboratório Teuto in Brazil
-
Kamada Affirms 2024 Financial Guidance and Announces Expected Continued Double-Digit Profitable Growth for 2025
-
Blue Sky Announces Mailing and Filing of Circular for Special Meeting of Shareholders to Approve the Earn-In Agreement with COAM
-
Dianthus Therapeutics to Webcast Presentation at the 43rd Annual J.P. Morgan Healthcare Conference
-
Alesta Therapeutics Raises €65 Million Series A Financing to Advance Oral Small Molecules for Rare Diseases
-
BioStem Technologies Launches Clinical Trial to Demonstrate the Therapeutic Benefits of its BioREtain® Technology in Treating Diabetic Foot Ulcers Using Vendaje®
-
Mantle Ridge Issues Shareholder Letter Outlining the Path Forward for Air Products and Chemicals, Inc.
-
Miami Beach and Blue Zones Join Forces to Transform Health of City
-
Best of 2024 Self-Service and Kiosk Awards
-
BIO-TECHNE TO PRESENT AT PHACILITATE ADVANCED THERAPIES WEEK 2025
-
Tonix Pharmaceuticals Further Strengthens Commercial Leadership Team with Appointment of Gary Ainsworth as Vice President of Market Access
-
ScaleReady Announces a G-Rex® Grant has been awarded to Seattle Children's Therapeutics
-
Western Exploration Reports Extension of High-grade Mineralization at Gravel Creek
-
Carvana Announces Auction-IRC ‘Megasite’ Integration in Atlanta Area
-
SynergenX Health and HerKare Empower Women with Testosterone Replacement Therapy
-
enBio Corp Launches Transformative Division to Change Biomedical Staffing Nationwide
-
PureTech to Present at 43rd Annual J.P. Morgan Healthcare Conference
-
Bruker Launches Infrared Imaging Microscope for Pharma and Life Science Research
-
Zetagen Therapeutics Expands IP Portfolio, Achieving a Milestone of 64 Worldwide Patents in 2024
-
InMode to Report Fourth Quarter & Full Year 2024 Financial Results and Hold Conference Call on February 6, 2025, Expects Q4 Revenue Between $97.0M-$97.5M
